Healthtech Startup Superceuticals Launches Instant Biochemical and Biophysical Analyser SC-AN 2.4

A standout feature is its capacity to generate instant reports, delivering results in just 10 minutes, thus ensuring rapid and efficient patient care. Driven by advanced technology, it surpasses traditional diagnostics by incorporating digital health records to elevate the overall patient experience.

Healthtech startup, Superceuticals has recently launched its SC-AN 2.4 biochemical and biophysical analyser. This system utilises advanced technologies such as electrical impedance, amperometry, voltammetry, cell counting, photometry, and immunological reactions with fluorescence assay to deliver accurate and clinically validated reports within minutes.'¯

The SC-AN 2.4 stands out for its capability to generate instant reports, delivering results in as little as 10 minutes. This fast speed ensures efficient patient care, enabling healthcare professionals to make informed decisions promptly.'¯

Further, SC-AN 2.4 helps medical practitioners provide accurate and timely treatments, thereby improving patient outcomes.

Superceuticals, founded in 2020 by Atman Jadon, is a Gurugram-based healthcare technology startup that develops and commercialises technological solutions in healthcare.

Commenting on the fundraise, Jadon, director of Superceuticals, said, 'œSC-AN 2.4 not only enhances diagnostic capabilities but also serves as an information system, disseminating critical healthcare information as needed. Our mobile application, complementing the system, curates a list of preferred medical providers and best treatment practices through artificial intelligence.'

As per the startup, the SC-AN 2.4 being powered by cutting-edge technology goes beyond conventional diagnostics by incorporating digital health records. This integration enhances the overall patient experience and streamlines the retrieval and analysis of medical data.'¯

By seamlessly integrating with electronic health record systems, SC-AN 2.4 aims to promote interoperability and enables healthcare professionals to access comprehensive patient information, leading to more informed diagnoses and personalised treatment plans.

Futhermore, the SC-AN 2.4 is equipped to analyse over 85 parameters, covering a wide range of biochemical and biophysical measurements, said the startup. This enables comprehensive health assessments and aids in the early detection and monitoring of various medical conditions.'¯

The startup claims that the reports generated by SC-AN 2.4 are clinically validated, ensuring the accuracy and reliability of the diagnostic results. This reliability aims to instil confidence in both healthcare providers and patients, fostering a solid foundation for effective medical decision-making.

In addition to its clinical benefits, the SC-AN 2.4 also advocates environmental sustainability. This diagnostic system minimises its ecological footprint by reducing sample handling, reagent usage, and the need for transportation.'¯

The optimisation of resources contributes to a greener healthcare environment and leads to cost savings for healthcare providers.

Another key feature of the SC-AN 2.4 is its patient-friendly sample collection process. Unlike traditional diagnostic methods that require invasive procedures, the SC-AN 2.4 simplifies the sample collection process by requiring a minimal amount of blood obtained through a straightforward finger prick. This non-invasive approach aims to reduce patient discomfort and enhance the overall patient experience.'¯

The SC-AN 2.4's user-friendly design and accessibility eliminate the need for extensive medical training and allow more professionals to utilise its capabilities effectively.